Beyond helping UPHS to enhance its response to HAIs and its antimicrobial stewardship capabilities, TheraDoc will continuously monitor electronic patient records to identify infections in real-time. Concurrently, it will deliver the clinical data and relevant patient information that will assist UPHS clinicians in reducing and preventing healthcare-acquired infections.
To support the research projects, enable proactive, real-time infection management and prevention, and streamline internal and external infection rate reporting, TheraDoc will integrate its Expert System Platform® and Infection Control Assistant(TM) on-site with the healthcare information systems at UPHS to leverage existing data assets.
Further enhancements will result as TheraDoc implements additional components of its injury detection and prevention systems, including the Antibiotic Assistant®, ADE Assistant® and Clinical Alerts Assistant(TM). These knowledge modules will help UPHS clinicians with their clinical decision-making and further enhance antimicrobial stewardship and management.
In addition, TheraDoc will assist clinicians in identifying adverse drug events by rapidly identifying intervention opportunities for patients at risk, notifying clinicians in real-time and delivering critical data via e-mail, handheld or pager.
Stan Pestotnik, TheraDoc president and CEO, said, "We are privileged to implement our technology to further improve patient safety measures at the three hospitals that comprise the University of Pennsylvania Health System that are consistently ranked among the best in the nation. He further stated, "TheraDoc has a non-negotiable adherence to healthcare industry standards. It is interesting to note that our software is fully compliant with the comprehensive procurement guidelines established by UPHS and the State of
Source: TheraDoc, Inc.